Skip to main content
TVPills

Praluent Alternatives

Drugs like Praluent (alirocumab) — other cardiovascular medications advertised on TV that may be alternatives. Informational only — not medical advice. Only your doctor can decide what's right for you.

Unverified catalogue summary (alternative grouping) for Praluent in US; not checked against current local product information.

Share

Eliquis

apixaban · Bristol-Myers Squibb/Pfizer

Treats Blood clots, nonvalvular atrial fibrillation

Unverified catalogue summary (alternative identity, manufacturer and indication) for Eliquis in US; not checked against current local product information.

Details Cost

Xarelto

rivaroxaban · Janssen Pharmaceuticals, Inc.

Treats Blood clots, nonvalvular atrial fibrillation

Unverified catalogue summary (alternative identity, manufacturer and indication) for Xarelto in US; not checked against current local product information.

Details Cost

Entresto

sacubitril/valsartan · Novartis

Treats Chronic heart failure

Unverified catalogue summary (alternative identity, manufacturer and indication) for Entresto in US; not checked against current local product information.

Details Cost

Repatha

evolocumab · Amgen

Treats High cholesterol, cardiovascular disease

Unverified catalogue summary (alternative identity, manufacturer and indication) for Repatha in US; not checked against current local product information.

Details Cost

Brilinta

ticagrelor · AstraZeneca Pharmaceuticals LP (US distributor)

Treats Acute coronary syndrome, heart attack prevention

Unverified catalogue summary (alternative identity, manufacturer and indication) for Brilinta in US; not checked against current local product information.

Details Cost

Leqvio

inclisiran · Novartis

Treats High cholesterol

Unverified catalogue summary (alternative identity, manufacturer and indication) for Leqvio in US; not checked against current local product information.

Details Cost

Vascepa

icosapent ethyl · Amarin Pharma, Inc. (US distributor; manufactured for Amarin Pharmaceuticals Ireland Limited)

Treats High triglycerides, cardiovascular risk reduction

Unverified catalogue summary (alternative identity, manufacturer and indication) for Vascepa in US; not checked against current local product information.

Details Cost

Lipitor

atorvastatin · Viatris Specialty LLC (US distributor)

Treats High cholesterol, cardiovascular prevention

Unverified catalogue summary (alternative identity, manufacturer and indication) for Lipitor in US; not checked against current local product information.

Details Cost

Crestor

rosuvastatin · AstraZeneca Pharmaceuticals LP (US distributor)

Treats High cholesterol, cardiovascular prevention

Unverified catalogue summary (alternative identity, manufacturer and indication) for Crestor in US; not checked against current local product information.

Details Cost

Lisinopril

lisinopril · Various (generic)

Treats High blood pressure, heart failure

Unverified catalogue summary (alternative identity, manufacturer and indication) for Lisinopril in US; not checked against current local product information.

Details Cost

Vyndamax

tafamidis · Pfizer

Treats Transthyretin amyloid cardiomyopathy

Unverified catalogue summary (alternative identity, manufacturer and indication) for Vyndamax in US; not checked against current local product information.

Details Cost

Camzyos

mavacamten · Bristol-Myers Squibb

Treats Obstructive hypertrophic cardiomyopathy

Unverified catalogue summary (alternative identity, manufacturer and indication) for Camzyos in US; not checked against current local product information.

Details Cost
See all Cardiovascular medications

Sources and editorial standards

Product-label references, not clinical verification. Medicine identification—not prescribing guidance. This page does not provide a complete safety or dosing reference. Check the official label for your country and exact product, and consult your pharmacist or prescriber before starting, stopping or changing treatment. Missing information does not mean a medicine is safe for you. Reference formulation scope (not dosing instructions): alirocumab SC solution, 75 mg/mL and 150 mg/mL single-dose prefilled pens

Unresolved / not established by these sources:

  • Clinical summaries, safety tiers and dosing guidance are withheld while their review remains unfinished.
  • A linked document may have been superseded. Confirm country, product, formulation and latest revision with the regulator or pharmacist.

Lookup resources (not product-specific citations; confirm formulation and country before use):

Frequently asked questions

What drugs are similar to Praluent?

Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Drugs like Praluent include other cardiovascular medications advertised on TV such as Eliquis, Xarelto, Entresto and more. This is an editorial catalogue grouping, not a verified comparison of indications, safety or suitable substitutes. Ask your prescriber about treatment choices.

What can I take instead of Praluent?

Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Other cardiovascular medications advertised on TV include Eliquis, Xarelto, Entresto and others. The right alternative depends on your diagnosis, medical history and insurance — only your doctor can recommend a substitute for Praluent. This page is informational only.

Is there a generic version of Praluent?

Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Praluent is sold as alirocumab. Whether a lower-cost generic is available depends on patent status — ask your pharmacist, and see the cost & savings page for ways to pay less.

Are these alternatives the same as Praluent?

Unverified catalogue grouping, not a clinically established substitute or a checked local indication. This catalogue grouping does not establish therapeutic equivalence, shared approved indications or suitability as a substitute. Do not switch medicines based on it; consult your prescriber.